Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and its<i>in-vitro</i>anticancer activity-Reference-Cited by-同舟云学术

Empagliflozin containing chitosan-alginate nanoparticles in orodispersible film: preparation, characterization, pharmacokinetic evaluation and itsin-vitroanticancer activity

Published:2022-07-03 Issue:7 Volume:48 Page:279-291
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Sinha Suhani¹,Sonali ²,Garg Vandana³,Thapa Sonia⁴,Singh Shashank⁴,Chauhan Mahima¹,Dutt Rohit¹^ORCID,Singh Rahul Pratap¹^ORCID

Affiliation:

1. Department of Pharmacy, School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, Haryana, India

2. Guru Teg Bahadur Hospital, GTB Enclave, Dilshad Garden, New Delhi, Delhi, India

3. Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India

4. Academy of Scientific and Innovative Research, CSIR-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir, India

Funder

Science and Engineering Research Board (SERB), New Delhi, India

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2022.2108829

Reference57 articles.

1. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204629Orig1s000SumR.pdf.

2. https://www.medicines.org.uk/emc/product/5441/smpc.

3. https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Glyxambi/Glyxambi.pdf

4. BroedlU Eynatten MV, Macha S, Woerle HJ, et al., Inventors; Boehringer Ingelheim, assignee. Therapeutic uses of empagliflozin. WO2014161919A1. 2014.

5. Kaushik VK, Tummanepally JMC, Pothani J, et al., inventors, Mylan Laboratories Limited, assignee. Process for the preparation of empagliflozin. WO2015101916A1. 2015.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orodispersible Films: Current Innovations and Emerging Trends;Pharmaceutics;2023-12-11

2. Nanoparticles with SGLT2 inhibitory activity: Possible benefits and future;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2023-10

3. Empagliflozin: a potential anticancer drug;Discover Oncology;2023-07-12

4. Comparative Evaluation of Metformin and Metronidazole Release from Oral Lyophilisates with Different Methods;Scientia Pharmaceutica;2023-04-25

5. Nanomedicine in the Treatment of Metabolic Diseases;Learning Materials in Biosciences;2023